Review
Neuroendocrine hormones such as growth hormone and prolactin are integral members of the immunological cytokine network☆

https://doi.org/10.1016/j.cellimm.2007.12.003Get rights and content

Abstract

Neuroendocrine hormones such as growth hormone (GH) and prolactin (PRL) have been demonstrated to accelerate the recovery of the immune response after chemotherapy and bone marrow transplantation and to enhance the restoration of immunity in individuals infected with HIV and in normal individuals with compromised immune systems associated with aging. As the mechanism of action of these hormones has been elucidated, it has become clear that they are integral members of the immunological cytokine/chemokine network and share regulatory mechanisms with a wide variety of cytokines and chemokines. The members of this cytokine network induce and can be regulated by members of the suppressor of cytokine signaling (SOCS) family of intracellular proteins. In order to take advantage of the potential beneficial effects of hormones such as GH or PRL, it is essential to take into consideration the overall cytokine network and the regulatory effects of SOCS proteins.

Introduction

This review focuses on the effects of GH, PRL and GH-related molecules on the immune system, particularly as these molecules are used to alter immune competency. The review will summarize some of the experimental model systems and clinical applications in which GH and GH-related molecules have been shown to have positive effects on the immune system. We will then summarize examinations of the mechanisms of GH activity. Recent studies of GH activity have clearly shown that GH must be considered in a broader context that includes cytokines and chemokines. All of these molecules share common regulatory mechanisms mediated by the suppressor of cytokine signaling (SOCS) family of molecules. We will also illustrate some of the ways in which GH-related molecules, cytokines and chemokines can interact with each other via the regulatory effects of SOCS proteins. Finally, we will summarize recent studies that have taken into account the interplay among these systems and then devised strategies to circumvent problems such as GH resistance.

Section snippets

Bone marrow transplantation

The pituitary-derived hormones GH, PRL and the GH-stimulated molecule insulin-like growth factor-1 (IGF-1) have all been demonstrated to accelerate recovery of the immune system following transplantation of various types of cells. For example, Murphy et al. [1] transplanted murine thymocytes or human PBL into SCID mice and demonstrated that treatment with recombinant human GH (rhGH) stimulated increased engraftment of cells from both species. Other studies from this group showed that GH could

Mechanism of GH actions and regulation

While detailed accounts of the mechanisms by which GH and its upstream and downstream related molecules act on cells and how these signaling pathways are regulated are well beyond the scope of this review, it is important to emphasize that GH-stimulated effects share mechanisms with a large family of cytokines and chemokines. The shared pathways suggest that these molecules have common regulatory mechanisms. In fact, there are shared regulatory components and these components exhibit a high

Ghrelin

Although the discussion to this point has focused primarily on the direct and downstream effects of PRL and GH and how these effects interact with regulate and can be regulated by cytokines and chemokines, upstream molecules that stimulate GH production have interesting and somewhat unexpected effects that should also be noted. In some cases, upstream effector molecules produce exactly the sorts of effects that one would expect as illustrated by two types of findings. The production of GH by

Future directions

We began this review by noting some of the many studies demonstrating that neuroendocrine hormones such as GH and PRL can have beneficial effects on the immune system, particularly when it has been compromised by disease, therapy or aging. However, these hormones use the same pathways and are subject to the same feedback regulatory effects of SOCS proteins as do inflammatory cytokines and others required for normal immune responses. Elevated levels of SOCS proteins can be protective by

References (99)

  • J. Piessevaux et al.

    Functional cross-modulation between SOCS proteins can stimulate cytokine signaling

    J. Biol. Chem.

    (2006)
  • C.J. Greenhalgh et al.

    Biological evidence that SOCS-2 can act either as an enhancer or suppressor of growth hormone signaling

    J. Biol. Chem.

    (2002)
  • A. Pezet et al.

    Inhibition and restoration of prolactin signal transduction by suppressors of cytokine signaling

    J. Biol. Chem.

    (1999)
  • Z. Dogusan et al.

    Expression of SOCS genes in normal and leukemic human leukocytes stimulated by prolactin, growth hormone and cytokines

    J. Neuroimmunol.

    (2000)
  • E.E. Spangenburg

    SOCS-3 induces myoblast differentiation

    J. Biol. Chem.

    (2005)
  • J. Bayle et al.

    Suppressor of cytokine signaling 6 associates with KIT and regulates KIT receptor signaling

    J. Biol. Chem.

    (2004)
  • H.T. Chen et al.

    Growth hormone receptor and regulation of gene expression in fetal lymphoid cells

    Mol. Cell Endocrinol.

    (1998)
  • B. Derfalvi et al.

    Growth hormone receptor gene expression on human lymphocytic and monocytic cell lines

    Cell Biol. Int.

    (1998)
  • R. Garzon et al.

    CXCR4-mediated suppressor of cytokine signaling up-regulation inactivates growth hormone function

    J. Biol. Chem.

    (2004)
  • O.M. Pello et al.

    SOCS up-regulation mobilizes autologous stem cells through CXCR4 blockade

    Blood

    (2006)
  • K.E. Mayo et al.

    Growth hormone-releasing hormone: synthesis and signaling

    Recent Prog. Horm. Res.

    (1995)
  • R.G. Smith et al.

    Developments in ghrelin biology and potential clinical relevance

    Trends Endocrinol. Metab.

    (2005)
  • R.G. Smith et al.

    Adenosine: a partial agonist of the growth hormone secretagogue receptor

    Biochem. Biophys. Res. Commun.

    (2000)
  • E. Gonzalez-Rey et al.

    Therapeutic action of ghrelin in a mouse model of colitis

    Gastroenterology

    (2006)
  • A. Baetz et al.

    Suppressor of cytokine signaling (SOCS) proteins indirectly regulate toll-like receptor signaling in innate immune cells

    J. Biol. Chem.

    (2004)
  • D.D. Taub

    Novel connections between the neuroendocrine and immune systems: the ghrelin immunoregulatory network

    Vitam. Horm.

    (2007)
  • W.J. Murphy et al.

    Human growth hormone promotes engraftment of murine or human T cells in severe combined immunodeficient mice

    Proc. Natl. Acad. Sci. USA

    (1992)
  • W.J. Murphy et al.

    Role of neuroendocrine hormones in murine T cell development. Growth hormone exerts thymopoietic effects in vivo

    J. Immunol.

    (1992)
  • Z.G. Tian et al.

    Recombinant human growth hormone promotes hematopoietic reconstitution after syngeneic bone marrow transplantation in mice

    Stem Cells

    (1998)
  • M.A. Woody et al.

    Use of neuroendocrine hormones to promote reconstitution after bone marrow transplantation

    Neuroimmunomodulation

    (1999)
  • O. Alpdogan et al.

    Insulin-like growth factor-I enhances lymphoid and myeloid reconstitution after allogeneic bone marrow transplantation

    Transplantation

    (2003)
  • C.S. Nicoll et al.

    Structural features of prolactins and growth hormones that can be related to their biological properties

    Endocr. Rev.

    (1986)
  • B. Sirohi et al.

    Use of physiological doses of human growth hormone in haematological patients receiving intensive chemotherapy promotes haematopoietic recovery: a double-blind randomized, placebo-controlled study

    Bone Marrow Transplant

    (2007)
  • J. Tacke et al.

    Long-term risk of gastrointestinal tumor recurrence after postoperative treatment with recombinant human growth hormone

    JPEN J. Parenter. Enteral Nutr.

    (2000)
  • S.L. Nightingale

    From the food and drug administration

    JAMA

    (1995)
  • B.Y. Nguyen et al.

    Pilot study of the immunologic effects of recombinant human growth hormone and recombinant insulin-like growth factor in HIV-infected patients

    Aids

    (1998)
  • A.J. Krentz et al.

    Anthropometric, metabolic, and immunological effects of recombinant human growth hormone in AIDS and AIDS-related complex

    J. Acquir. Immune Defic. Syndr.

    (1993)
  • S.A. Lieberman et al.

    Anabolic effects of recombinant insulin-like growth factor-I in cachectic patients with the acquired immunodeficiency syndrome

    J. Clin. Endocrinol. Metab.

    (1994)
  • K.J. Ellis et al.

    Changes in body composition of human immunodeficiency virus-infected males receiving insulin-like growth factor I and growth hormone

    J. Clin. Endocrinol. Metab.

    (1996)
  • P.D. Lee et al.

    A randomized placebo-controlled trial of combined insulin-like growth factor I and low dose growth hormone therapy for wasting associated with human immunodeficiency virus infection

    J. Clin. Endocrinol. Metab.

    (1996)
  • L.A. Napolitano et al.

    Increased thymic mass and circulating naive CD4 T cells in HIV-1-infected adults treated with growth hormone

    Aids

    (2002)
  • A. Pires et al.

    differentiation and function in HIV-1-infected individuals after growth hormone and highly active antiretroviral therapy

    Antivir. Ther.

    (2004)
  • M.R. Goodier et al.

    Loss of the CD56hiCD16-NK cell subset and NK cell interferon-gamma production during antiretroviral therapy for HIV-1: partial recovery by human growth hormone

    Clin. Exp. Immunol.

    (2003)
  • K.W. Kelley et al.

    GH3 pituitary adenoma cells can reverse thymic aging in rats

    Proc. Natl. Acad. Sci. USA

    (1986)
  • R.A. French et al.

    Age-associated loss of bone marrow hematopoietic cells is reversed by GH and accompanies thymic reconstitution

    Endocrinology

    (2002)
  • E. Montecino-Rodriguez et al.

    Effects of insulin-like growth factor administration and bone marrow transplantation on thymopoiesis in aged mice

    Endocrinology

    (1998)
  • G.C. Koo et al.

    Immune enhancing effect of a growth hormone secretagogue

    J. Immunol.

    (2001)
  • J.A. Martial et al.

    Human growth hormone: complementary DNA cloning and expression in bacteria

    Science

    (1979)
  • W.G. Roskam et al.

    Molecular cloning and nucleotide sequence of the human growth hormone structural gene

    Nucleic Acids Res.

    (1979)

    • Cited by (63)

    • Repurposing prolactin as a promising immunomodulator for the treatment of COVID-19: Are common Antiemetics the wonder drug to fight coronavirus?

      2020, Medical Hypotheses

    • Multifactorial Regulation of GLH Hormones

      2016, Insights to Neuroimmune Biology: Second Edition

    • Arginine Vasopressin: An Immunoregulatory Hormone

      2016, Insights to Neuroimmune Biology: Second Edition

    • Androgen and prolactin manipulation do not induce changes in immunocompetence measures in a fish with male parental care

      2023, Journal of Experimental Zoology Part A: Ecological and Integrative Physiology

    • Neurotransmitters: promising immune modulators in the tumor microenvironment

      2023, Frontiers in Immunology

    • THYMIC GLAND ASPECTS IN CHILDHOOD: MORPHOFUNCTIONAL RECIPROCAL RELATIONSHIPS BETWEN THYMUS, NERVOUS AND ENDOCRINE SYSTEM, IN PARTICULAR, WITH THE SOMATOTROPHIC AXIS HORMONES

      2023, Medical Immunology (Russia)
    View all citing articles on Scopus
    ☆

    Supported in part by NIH 1 R01 AG022661 and the UNR Cytometry Center is supported in part by the Nevada INBRE NIH 2 P20 RR016464 and the Intramural Research Program of the National Institute on Aging, National Institutes of Health.

    View full text
    Copyright © 2008 Elsevier Inc. All rights reserved.